System Transmission

Top Signal

100#1 JOB

Activity

2180Ripe

+936 today

System

Livenow

Terminal Asset View

stockNASDAQ

BIVI

$1.41+1.44%

BioVie Inc - Class A

Ripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

85Ripe

Live Analysis Active

Company Mission

BioVie Inc develops drugs to treat serious diseases like Parkinson's and liver cirrhosis. Patients and doctors use these treatments to manage symptoms and improve health outcomes. The company makes money by advancing its drug candidates through clinical trials and seeking partnerships or approvals for commercialization.

BIV

Industry Context

The biotechnology industry is characterized by high innovation and significant investment in drug development, particularly for complex diseases like neurological and liver conditions. BioVie operates in this competitive space, focusing on therapies that address unmet medical needs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

94Matrix

Market Momentum

58.3— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.5x— Normal Volume

Today's Change

1.44%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-0

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing BIVI across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:02 AM UTC

As-of 03-16-2026 05:47 UTC (Equities data delayed ~15 min)

Biovie focuses on developing treatments for neurological and liver diseases, which are large and growing markets with high unmet medical needs, making it a strong contender in the biotech industry.

A technical pattern is forming near one dollar and forty-one cents, suggesting bullish momentum as the price has stabilized after recent movements.

Volume spiked at one dollar and forty-one cents, indicating potential buyer interest because this level has acted as a support area in the past.

Industry trends in biotechnology are driving strength, with price holding above one dollar and forty-one cents, signaling resilience in a volatile sector.

Educational only. Not investment advice. Equities data may be ~15m delayed.

Precision Intelligence Model

Live Terminal Stream

Loading chart...